Biomedical Catalyst

The BMC offers funding to small and medium-sized enterprises (SMEs) to support development of innovative solutions to health and healthcare challenges. For industry–led projects that focus on disease prevention and proactive management of health and chronic conditions, earlier and better detection and diagnosis of disease, tailored treatments and/or digital health technologies. Interested? Feel free to contact us!

Scope

Support for UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes. Projects must focus developing a product or process that is an innovative solution to a defined health or care challenge. Your project can focus on:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures
  • the development of digital health technologies

This list is not intended to be exhaustive.

The Industry-led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

Your project can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • a demonstration of clinical utility and effectiveness
  • a demonstration of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Specific Themes

Your project can focus on any health or healthcare sector or discipline.

The Biomedical Catalyst now incorporates the Digital Health Technology Catalyst and will support digital health projects.

Your project can align with one or more of the following Innovation areas:

  • biosciences
  • advanced therapies (gene and cell therapies)
  • diagnostic, medical technology and devices
  • digital health
  • independent living and wellbeing
  • precision medicine
  • preclinical technologies and drug target discovery
  • therapeutic and medicine development

This list is not intended to be exhaustive.

Projects that will not be funded

  • are not related to human life sciences
  • focus on a product that is already on the market
  • focus on laboratory accreditation
  • are conducted to anything less than the highest standards of animal welfare
  • are dependent on export performance – for example giving a subsidy to a baker on the condition that it exports a certain quantity of bread to another country
  • are dependent on domestic inputs usage – for example giving a subsidy to a baker on the condition that it uses 50% UK flour in their product

Eligibility

  • Subsidy Control and EC State Aid funding rules apply
  • Project must be led by a UK business of any size and collaborators must be UK based organisations
  • R&D work must be carried out in the UK and project results exploited from UK.
  • Subcontractors can be from UK/overseas, with costs justified and appropriate to the total eligible project costs.

How PNO can support you

The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.

Contact us for further information







     privacy statement is applicable